← Calendar
Readoutin 76d
Celltrion — CT-P51
Phase 3 primary completion: A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer.
- Date
- Feb 2027
- Type
- Readout
- Indication
- Non Squamous Non Small Cell Lung Cancer
Source ↗Add to calendar
Get told when this date moves
The weekly brief is free. Pro adds reminders 7 days and 1 day before.
More from Celltrion
Mar2027
Readoutin 104d
Celltrion — CT-P44(Daratumumab)Phase 3 primary completion: A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma.